Cannabis in Germany

The Coronavirus pandemic has influenced the cannabis industry in that supply of medical cannabis is very much dependent on imports. After the legalisation of medical cannabis in 2017, the first national production is expected to deliver at the beginning of 2021. While cannabis for recreational purposes remains illegal, CBD products are seeing increasing demand and nurturing consumer interest in cannabis products.

The Cannabis in Germany market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2024 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Cannabis market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.